Literature DB >> 17917849

Distinctions between the dementia in amyotrophic lateral sclerosis with frontotemporal dementia and the dementia of Alzheimer's disease.

Jennifer Heidler-Gary1, Argye E Hillis.   

Abstract

The clinical entity of Amyotrophic Lateral Sclerosis with Frontotemporal Dementia (ALS-FTD) has only recently been recognized as an important neurodegenerative disease. As in isolated FTD, the behavioral and personality changes in ALS-FTD might be more characteristic than its cognitive changes. We aimed to characterize the behavioral and cognitive deficits in ALS-FTD, and contrast this profile with that of the most common form of dementia, AD, to assist ALS clinicians in recognizing the syndrome early in its course. Specifically, we hypothesized that a modified version of the Frontal Behavioral Inventory (FBI-mod), a brief questionnaire self-administered by a caregiver, along with just a few cognitive tests, would be clinically useful in distinguishing the dementia in ALS-FTD from the dementia of AD. We administered a battery of neuropsychological tests to 15 patients who met established criteria for Amyotrophic Lateral Sclerosis with Frontotemporal Dementia and to 30 patients who met established criteria for probable Alzheimer's disease. The FBI-mod was completed by caregivers. We found that the FBI-mod, age-corrected Z scores for the Mini-Mental State Examination (MMSE), a test of delayed recall, and a word fluency measure together discriminated between ALS-FTD and AD. ALS-FTD was characterized by more abnormal FBI scores and poor word fluency, in the presence of relatively normal overall cognitive status (MMSE) and/or delayed recall.

Entities:  

Mesh:

Year:  2007        PMID: 17917849     DOI: 10.1080/17482960701381911

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  5 in total

1.  Diffusion tensor tract-specific analysis of the uncinate fasciculus in patients with amyotrophic lateral sclerosis.

Authors:  Kanako Sato; Shigeki Aoki; Nobue K Iwata; Yoshitaka Masutani; Takeyuki Watadani; Yasuhiro Nakata; Mariko Yoshida; Yasuo Terao; Osamu Abe; Kuni Ohtomo; Shoji Tsuji
Journal:  Neuroradiology       Date:  2010-02-20       Impact factor: 2.804

2.  Disease progression in C9orf72 mutation carriers.

Authors:  Mary K Floeter; Bryan J Traynor; Jennifer Farren; Laura E Braun; Michael Tierney; Edythe A Wiggs; Tianxia Wu
Journal:  Neurology       Date:  2017-06-14       Impact factor: 9.910

Review 3.  The non-fluent/agrammatic variant of primary progressive aphasia.

Authors:  Murray Grossman
Journal:  Lancet Neurol       Date:  2012-05-16       Impact factor: 44.182

Review 4.  Primary progressive aphasia: clinicopathological correlations.

Authors:  Murray Grossman
Journal:  Nat Rev Neurol       Date:  2010-02       Impact factor: 42.937

Review 5.  Psychometric Properties of Cognitive Assessment in Amyotrophic Lateral Sclerosis: A Systematic Review.

Authors:  Tina Taule; Margaret Søvik; Regina Küfner Lein; Eike Wehling; Jörg Aßmus; Tiina Rekand
Journal:  Patient Relat Outcome Meas       Date:  2020-09-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.